Midazolam Injection, Solution
Product Images NDC 0409-2308

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 0409-2308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Midazolam 01)

FDA Label Image

Chemical Structure (Midazolam 01a)

FDA Label Image

Chemical Structure (Midazolam 02)

Chemical Structure (Midazolam 02)
Midazolam Open-ring Form is a type of medication used to induce sedation, reduce anxiety, and help patients relax before and during surgical procedures. It belongs to the benzodiazepine drug class and works by acting on the central nervous system. This form of midazolam has an open-ring structure, which increases its solubility and potency compared to other forms. It is usually administered through injection and can rapidly produce sedative effects. However, it can also cause side effects such as confusion, dizziness, and respiratory depression.*
FDA Label Image

Chart (Midazolam 03)

FDA Label Image

Logo (Midazolam 04)

FDA Label Image

Principal Display Panel (2 mL Vial Label RL-7447)

Principal Display Panel (2 mL Vial Label RL-7447)
This is a description of a 2 mL single-dose vial of Midazolam, a prescription medication used for intravenous or intramuscular use. It contains 2mg/2mL of Midazolam and is preservative-free. Unused portions should be discarded. It is distributed by Hospira Inc. in Lake Forest, IL. The additional characters at the end are not readable and may have been caused by an error during the process.*
FDA Label Image

Principal Display Panel (2 mL Vial Box CA-7201)

Principal Display Panel (2 mL Vial Box CA-7201)
Each milliliter of this solution contains midazolam hydrochloride equivalent to 1mg midazolam with 0.8% sodium chloride. The solution is likely to be manufactured in Italy. The pH of this solution is approximately 3 (25 to 35 adjusted with hydrochloride and, if needed, sodium hydroxide). The rest of the text is not readable.*
FDA Label Image

Principal Display Panel (5 mL Vial Label RL-7448)

Principal Display Panel (5 mL Vial Label RL-7448)
This is a description of a medication in the form of a single-dose vial with a volume of 5mL. The medication product has an NDC code of 0409-2305-04, contains Mldazol at a concentration of 5mg/5mL (1mg/mL), and is preservative-free. It is intended for LV. or .M. use and is Rx only. The unused portion should be discarded. The medication is distributed by Hospira, Inc. based in Lake Forest, IL, USA. The rest of the text is not readable and contains errors.*
FDA Label Image

Principal Display Panel (5 mL Vial Box CA7202)

Principal Display Panel (5 mL Vial Box CA7202)
This is a prescription drug with NDC 0409-2205.05 and is available in 10 single-dose Flip-top Vials. The drug is Midazolam, which is administered intravenously or intramuscularly and used as a sedative. The solution is in a preservative-free form and compounds 1 mg of Midazolam with 0.8% sodium chloride. The recommended storage temperature is between 20 to 25 degrees Celsius. The expiry date is not available in the given text.*
FDA Label Image

Principal Display Panel (1 mL Vial Label RL-7449)

FDA Label Image

Principal Display Panel (1 mL Vial Box CA7205)

Principal Display Panel (1 mL Vial Box CA7205)
This is a prescription drug contained in a vial with a flip top, which contains midazolam hydrochloride at a concentration of 5 mg/mL. One box contains ten 1-mL vials. It is a preservative-free medication for intravenous or intramuscular use. The pH of this drug is around 3.25 to 3.35, adjusted with hydrochloric acid and sodium chloride. The prescribed dosage needs to be referred to the insert. It is produced and distributed in the United States by Hospira, Inc. in Lake Forest, Illinois.*
FDA Label Image

Principal Display Panel (2 mL Vial Label RL-7450)

Principal Display Panel (2 mL Vial Label RL-7450)
This is a description for a 2mL single-dose vial of Midazolam, with a concentration of 10mg/2mL (5mg/mL) for intravenous or muscular use. The vial is preservative-free and manufactured by Hospira, Inc. It has a National Drug Code (NDC) of 0409-2308 and should be discarded if unused. There is also a product code of RL-7450 and a lot number that is illegible.*
FDA Label Image

Principal Display Panel (2 mL Vial Box CA7206)

Principal Display Panel (2 mL Vial Box CA7206)
This is a prescription-only medication - midazolam - contained in a single-dose vial that is preservative-free and sterile, with a concentration of 10mg/2mL. The medication is intended for intravenous or intramuscular use, and the usual dosage should be reviewed. The vial must be stored at a controlled room temperature of 20-25°C (68-77°F). The medication is distributed by Hospira, Inc., based in Lake Forest, IL, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.